Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 4, 2024HistopathologyOpen Access

Identifying mesonephric‐like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMaryam TahirDXDeyin XingQDQingqing Ding

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tahir et al. (2024) studied this question.

synapsesocial.com/papers/68e59566b6db6435875306eahttps://doi.org/10.1111/his.15312
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<scp>SOX17</scp> expression in mesonephric‐like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Müllerian biomarker2024 · 6 citations
  2. 2SOX17/PAX8 dual immunohistochemical expression in the diagnosis of Müllerian carcinomas2026 · 2 citations
  3. 3Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma2024 · 2 citations
  4. 477 Advanced-Stage Uterine Mesonephric-Like Adenocarcinoma Without Endometrial Involvement: A Diagnostic Challenge2025
  5. 5Endometrial Mesonephric-Like Carcinoma With Prominent Clear Cell Carcinoma-Like Features.2025